{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:30:56Z","timestamp":1773397856394,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12874-018-0561-3","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T10:23:33Z","timestamp":1538043813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals"],"prefix":"10.1186","volume":"18","author":[{"given":"Guillermo","family":"Prada-Ramallal","sequence":"first","affiliation":[]},{"given":"Fatima","family":"Roque","sequence":"additional","affiliation":[]},{"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[]},{"given":"Bahi","family":"Takkouche","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-8672","authenticated-orcid":false,"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"561_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jclinepi.2006.08.012","volume":"60","author":"DD Terris","year":"2007","unstructured":"Terris DD, Litaker DG, Koroukian SM. Health state information derived from secondary databases is affected by multiple sources of bias. J Clin Epidemiol. 2007;60:734\u201341.","journal-title":"J Clin Epidemiol"},{"key":"561_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jclinepi.2006.10.019","volume":"60","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S. Understanding secondary databases: a commentary on \u201csources of bias for health state characteristics in secondary databases\u201d. J Clin Epidemiol. 2007;60:648\u201350.","journal-title":"J Clin Epidemiol"},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323\u201337.","journal-title":"J Clin Epidemiol"},{"key":"561_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jclinepi.2011.07.009","volume":"64","author":"JA Knottnerus","year":"2011","unstructured":"Knottnerus JA, Tugwell P. Requirements for utilizing health care-based data sources for research. J Clin Epidemiol. 2011;64:1051\u20133.","journal-title":"J Clin Epidemiol"},{"key":"561_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2014.8167","volume":"312","author":"JA Berlin","year":"2014","unstructured":"Berlin JA, Golub RM. Meta-analysis as evidence: building a better pyramid. JAMA. 2014;312:603\u20136.","journal-title":"JAMA"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/978-3-540-26577-1_21","volume-title":"Handbook of epidemiology","author":"M Blettner","year":"2005","unstructured":"Blettner M, Schlattmann P. Meta-analysis in epidemiology. In: Ahrens W, Pigeot I, editors. Handbook of epidemiology. Berlin: Springer; 2005. p. 829\u201359."},{"key":"561_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/ije\/dyn204","volume":"37","author":"JPT Higgins","year":"2008","unstructured":"Higgins JPT. Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158\u201360.","journal-title":"Int J Epidemiol"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40264-016-0492-z","volume":"40","author":"G Prada-Ramallal","year":"2017","unstructured":"Prada-Ramallal G, Takkouche B, Figueiras A. Diverging conclusions from the same meta-analysis in drug safety: source of data (primary versus secondary) takes a toll. Drug Saf. 2017;40:351\u20138.","journal-title":"Drug Saf"},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/aje\/kwt010","volume":"178","author":"D Madigan","year":"2013","unstructured":"Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013;178:645\u201351.","journal-title":"Am J Epidemiol"},{"key":"561_CR10","unstructured":"InCites Journal Citation Reports. Science citation index expanded - medicine. General & Internal Thomson Reuters. \n                    https:\/\/jcr.incites.thomsonreuters.com\n                    \n                  . Accessed 10 Sept 2018."},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12874-017-0453-y","volume":"17","author":"CM Faggion Jr","year":"2017","unstructured":"Faggion CM Jr, Bakas NP, Wasiak J. A survey of prevalence of narrative and systematic reviews in five major medical journals. BMC Med Res Methodol. 2017;17:176.","journal-title":"BMC Med Res Methodol"},{"key":"561_CR12","doi-asserted-by":"publisher","first-page":"e4178","DOI":"10.1136\/bmj.e4178","volume":"344","author":"S Hopewell","year":"2012","unstructured":"Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178.","journal-title":"BMJ"},{"key":"561_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1472-6947-14-71","volume":"14","author":"X Blanc","year":"2014","unstructured":"Blanc X, Collet TH, Auer R, Fischer R, Locatelli I, Iriarte P, et al. Publication trends of shared decision making in 15 high impact medical journals: a full-text review with bibliometric analysis. BMC Med Inform Decis Mak. 2014;14:71.","journal-title":"BMC Med Inform Decis Mak"},{"key":"561_CR14","doi-asserted-by":"publisher","first-page":"e012594","DOI":"10.1136\/bmjopen-2016-012594","volume":"6","author":"S Rehal","year":"2016","unstructured":"Rehal S, Morris TP, Fielding K, Carpenter JR, Phillips PP. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals. BMJ Open. 2016;6:e012594.","journal-title":"BMJ Open"},{"key":"561_CR15","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1001\/jama.287.21.2847","volume":"287","author":"M Callaham","year":"2002","unstructured":"Callaham M, Wears RL, Weber E. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA. 2002;287:2847\u201350.","journal-title":"JAMA"},{"key":"561_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408\u201314.","journal-title":"J Clin Epidemiol"},{"key":"561_CR17","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2009","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Univ of Ottawa; 2009. \n                    www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  . Accessed 10 Sept. 2018"},{"key":"561_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"561_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","volume":"18","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800\u20134.","journal-title":"Epidemiology"},{"key":"561_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7326\/M16-1754","volume":"166","author":"J Weiss","year":"2017","unstructured":"Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med. 2017;166:419\u201329.","journal-title":"Ann Intern Med"},{"key":"561_CR21","doi-asserted-by":"publisher","first-page":"j1909","DOI":"10.1136\/bmj.j1909","volume":"357","author":"M Bally","year":"2017","unstructured":"Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909.","journal-title":"BMJ"},{"key":"561_CR22","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"561_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamainternmed.2017.0212","volume":"177","author":"R Tariq","year":"2017","unstructured":"Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of Gastric Acid Suppression with Recurrent Clostridium difficile infection: a systematic review and meta-analysis. JAMA Intern Med. 2017;177:784\u201391.","journal-title":"JAMA Intern Med"},{"key":"561_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.7326\/M15-2650","volume":"164","author":"NM Maruthur","year":"2016","unstructured":"Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016;164:740\u201351.","journal-title":"Ann Intern Med"},{"key":"561_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/M15-1121","volume":"164","author":"S Paul","year":"2016","unstructured":"Paul S, Saxena A, Terrin N, Viveiros K, Balk EM, Wong JB. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis. Ann Intern Med. 2016;164:30\u201340.","journal-title":"Ann Intern Med"},{"key":"561_CR26","doi-asserted-by":"publisher","first-page":"i610","DOI":"10.1136\/bmj.i610","volume":"352","author":"L Li","year":"2016","unstructured":"Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies. BMJ. 2016;352:i610.","journal-title":"BMJ"},{"key":"561_CR27","doi-asserted-by":"publisher","first-page":"h3163","DOI":"10.1136\/bmj.h3163","volume":"350","author":"AO Molnar","year":"2015","unstructured":"Molnar AO, Fergusson D, Tsampalieros AK, Bennett A, Fergusson N, Ramsay T, et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ. 2015;350:h3163.","journal-title":"BMJ"},{"key":"561_CR28","doi-asserted-by":"crossref","unstructured":"Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015;351 h4451. Erratum in: BMJ 2015;351:h4937.","DOI":"10.1136\/bmj.h4451"},{"key":"561_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","volume":"385","author":"V Beral","year":"2015","unstructured":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer, Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015;385:1835\u201342.","journal-title":"Lancet"},{"key":"561_CR30","doi-asserted-by":"publisher","first-page":"g6269","DOI":"10.1136\/bmj.g6269","volume":"349","author":"A Bellemain-Appaix","year":"2014","unstructured":"Bellemain-Appaix A, Kerneis M, O'Connor SA, Silvain J, Cucherat M, Beygui F, et al. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ. 2014;349:g6269.","journal-title":"BMJ"},{"key":"561_CR31","doi-asserted-by":"publisher","first-page":"f6932","DOI":"10.1136\/bmj.f6932","volume":"348","author":"S Grigoriadis","year":"2014","unstructured":"Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ. 2014;348:f6932.","journal-title":"BMJ"},{"key":"561_CR32","doi-asserted-by":"publisher","first-page":"g2366","DOI":"10.1136\/bmj.g2366","volume":"348","author":"L Li","year":"2014","unstructured":"Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. BMJ. 2014;348:g2366.","journal-title":"BMJ"},{"key":"561_CR33","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312:1552\u201364.","journal-title":"JAMA"},{"key":"561_CR34","doi-asserted-by":"publisher","first-page":"f5298","DOI":"10.1136\/bmj.f5298","volume":"347","author":"BH Stegeman","year":"2013","unstructured":"Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:f5298.","journal-title":"BMJ"},{"key":"561_CR35","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamainternmed.2013.7430","volume":"173","author":"JR Maneiro","year":"2013","unstructured":"Maneiro JR, Salgado E, Gomez-Reino JJ. Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated inflammatory conditions: systematic review and meta-analysis. JAMA Intern Med. 2013;173:1416\u201328.","journal-title":"JAMA Intern Med"},{"key":"561_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7326\/0003-4819-157-7-201210020-00525","volume":"157","author":"L Hartling","year":"2012","unstructured":"Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS. Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Ann Intern Med. 2012;157:498\u2013511.","journal-title":"Ann Intern Med"},{"key":"561_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","volume":"156","author":"J Hsu","year":"2012","unstructured":"Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156:512\u201324.","journal-title":"Ann Intern Med"},{"key":"561_CR38","doi-asserted-by":"publisher","first-page":"e4260","DOI":"10.1136\/bmj.e4260","volume":"345","author":"D Caldeira","year":"2012","unstructured":"Caldeira D, Alarc\u00e3o J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012;345:e4260.","journal-title":"BMJ"},{"key":"561_CR39","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1136\/bmj.e5945","volume":"345","author":"GJ MacArthur","year":"2012","unstructured":"MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.","journal-title":"BMJ"},{"key":"561_CR40","doi-asserted-by":"publisher","first-page":"e4944","DOI":"10.1136\/bmj.e4944","volume":"345","author":"S Mantha","year":"2012","unstructured":"Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012;345:e4944.","journal-title":"BMJ"},{"key":"561_CR41","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1136\/bmj.e553","volume":"344","author":"J Silvain","year":"2012","unstructured":"Silvain J, Beygui F, Barth\u00e9l\u00e9my O, Pollack C Jr, Cohen M, Zeymer U, et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2012;344:e553.","journal-title":"BMJ"},{"issue":"9817","key":"561_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","volume":"379","author":"Rebecca F McKnight","year":"2012","unstructured":"McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379:721\u20138.","journal-title":"The Lancet"},{"key":"561_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/9780470693926.ch12","volume-title":"Systematic reviews in health care: meta-analysis in context","author":"M Egger","year":"2001","unstructured":"Egger M, Davey Smith G, Schneider M. Systematic reviews of observational studies. In: Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001. p. 211\u201327.","edition":"2"},{"key":"561_CR44","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/sim.1183","volume":"21","author":"PP Glasziou","year":"2002","unstructured":"Glasziou PP, Sanders SL. Investigating causes of heterogeneity in systematic reviews. Stat Med. 2002;21:1503\u201311.","journal-title":"Stat Med"},{"key":"561_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/9781119959946.ch13","volume-title":"Pharmacoepidemiology","author":"John Seeger","year":"2012","unstructured":"Seeger J, Daniel GW. Commercial Insurance Databases. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. 5th ed. Chichester, John Wiley & Sons; 2012. p. 189\u2013208."},{"key":"561_CR46","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"561_CR47","doi-asserted-by":"publisher","first-page":"i157","DOI":"10.1136\/bmj.i157","volume":"352","author":"L Zorzela","year":"2016","unstructured":"Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, et al. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157.","journal-title":"BMJ"},{"key":"561_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/pds.4411","volume":"27","author":"JM Cohen","year":"2018","unstructured":"Cohen JM, Wood ME, Hernandez-Diaz S, Nordeng H. Agreement between paternal self-reported medication use and records from a national prescription database. Pharmacoepidemiol Drug Saf. 2018;27:413\u201321.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"561_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jval.2011.08.005","volume":"15","author":"JM Gamble","year":"2012","unstructured":"Gamble JM, McAlister FA, Johnson JA, Eurich DT. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study. Value Health. 2012;15:191\u20137.","journal-title":"Value Health"},{"key":"561_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jadohealth.2016.12.024","volume":"60","author":"KK Upadhya","year":"2017","unstructured":"Upadhya KK, Santelli JS, Raine-Bennett TR, Kottke MJ, Grossman D. Over-the-counter access to oral contraceptives for adolescents. J Adolesc Health. 2017;60:634\u201340.","journal-title":"J Adolesc Health"},{"issue":"Suppl 3","key":"561_CR51","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(Suppl 3):S11\u201321.","journal-title":"Med Care"},{"key":"561_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1513\/AnnalsATS.201410-459OC","volume":"12","author":"AC Wu","year":"2015","unstructured":"Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12:161\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"561_CR53","doi-asserted-by":"publisher","first-page":"e61735","DOI":"10.1371\/journal.pone.0061735","volume":"8","author":"BA Fallis","year":"2013","unstructured":"Fallis BA, Dhalla IA, Klemensberg J, Bell CM. Primary medication non-adherence after discharge from a general internal medicine service. PLoS One. 2013;8:e61735.","journal-title":"PLoS One"},{"key":"561_CR54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jamadermatol.2014.5254","volume":"151","author":"KL Anderson","year":"2015","unstructured":"Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015;151:623\u20136.","journal-title":"JAMA Dermatol"},{"key":"561_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","volume":"25","author":"MA Fischer","year":"2010","unstructured":"Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284\u201390.","journal-title":"J Gen Intern Med"},{"key":"561_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/M13-1705","volume":"160","author":"R Tamblyn","year":"2014","unstructured":"Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study. Ann Intern Med. 2014;160:441\u201350.","journal-title":"Ann Intern Med"},{"key":"561_CR57","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","volume":"35","author":"K Kolandaivelu","year":"2014","unstructured":"Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35:3267\u201376.","journal-title":"Eur Heart J"},{"key":"561_CR58","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00431-014-2294-6","volume":"173","author":"MJ Kirkeby","year":"2014","unstructured":"Kirkeby MJ, Hansen CD, Andersen JH. Socio-economic differences in use of prescribed and over-the-counter medicine for pain and psychological problems among Danish adolescents--a longitudinal study. Eur J Pediatr. 2014;173:1147\u201355.","journal-title":"Eur J Pediatr"},{"key":"561_CR59","first-page":"7","volume":"10","author":"K Mukherjee","year":"2017","unstructured":"Mukherjee K, Kamal KM. Sociodemographic determinants of out-of-pocket expenditures for patients using prescription drugs for rheumatoid arthritis. Am Health Drug Benefits. 2017;10:7\u201315.","journal-title":"Am Health Drug Benefits"},{"key":"561_CR60","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/1475-6773.12700","volume":"53","author":"AJ Karter","year":"2018","unstructured":"Karter AJ, Parker MM, Solomon MD, Lyles CR, Adams AS, Moffet HH, et al. Effect of out-of-pocket cost on medication initiation, adherence, and persistence among patients with type 2 diabetes: The Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2018;53:1227\u201347.","journal-title":"Health Serv Res"},{"key":"561_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075256","volume":"8","author":"A Leong","year":"2013","unstructured":"Leong A, Dasgupta K, Bernatsky S, Lacaille D, Avina-Zubieta A, Rahme E. Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records. PLoS One. 2013;8:e75256.","journal-title":"PLoS One"},{"key":"561_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00228-011-1088-2","volume":"68","author":"Y Takahashi","year":"2012","unstructured":"Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol. 2012;68:123\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"561_CR63","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40264-017-0518-1","volume":"40","author":"G Prada-Ramallal","year":"2017","unstructured":"Prada-Ramallal G, Takkouche B, Figueiras A. Summarising the evidence for drug safety: a methodological discussion of different meta-analysis approaches. Drug Saf. 2017;40:547\u201358.","journal-title":"Drug Saf"},{"key":"561_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.295.1.90","volume":"295","author":"E Garfield","year":"2006","unstructured":"Garfield E. The history and meaning of the journal impact factor. JAMA. 2006;295:90\u20133.","journal-title":"JAMA"},{"key":"561_CR65","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/bmj.314.7079.497","volume":"314","author":"PO Seglen","year":"1997","unstructured":"Seglen PO. Why the impact factor of journals should not be used for evaluating research. BMJ. 1997;314:498\u2013502.","journal-title":"BMJ"},{"key":"561_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/bmj.39142.454086.AD","volume":"334","author":"H Brown","year":"2007","unstructured":"Brown H. How impact factors changed medical publishing\u2013and science. BMJ. 2007;334:561\u20134.","journal-title":"BMJ"},{"key":"561_CR67","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jclinepi.2006.10.022","volume":"60","author":"S Gerber","year":"2007","unstructured":"Gerber S, Tallon D, Trelle S, Schneider M, J\u00fcni P, Egger M. Bibliographic study showed improving methodology of meta-analyses published in leading journals 1993-2002. J Clin Epidemiol. 2007;60:773\u201380.","journal-title":"J Clin Epidemiol"},{"key":"561_CR68","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jclinepi.2016.11.002","volume":"82","author":"M Petropoulou","year":"2017","unstructured":"Petropoulou M, Nikolakopoulou A, Veroniki AA, Rios P, Vafaei A, Zarin W, et al. Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015. J Clin Epidemiol. 2017;82:20\u20138.","journal-title":"J Clin Epidemiol"},{"key":"561_CR69","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/EDE.0b013e31820f31e1","volume":"22","author":"WA Ray","year":"2011","unstructured":"Ray WA. Improving automated database studies. Epidemiology. 2011;22:302\u20134.","journal-title":"Epidemiology"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12874-018-0561-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:33:39Z","timestamp":1569526419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-018-0561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/s12874-018-0561-3","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"97"}}